¼øÈ¯±â°ú¿ë ÀüÀڰǰ±â·Ï(EHR) ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, Á¦Ç°º°, ºñÁî´Ï½º ¸ðµ¨º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2033³â)
Cardiology EHR Market Size, Share & Trends Analysis Report By Product (Web/ Cloud-based EHR, On-premise EHR), By Business Model (Professional Services), By End Use, By Region, And Segment Forecasts, 2025 - 2033
»óǰÄÚµå
:
1771745
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 100 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼øÈ¯±â°ú¿ë ÀüÀڰǰ±â·Ï(EHR) ½ÃÀå °³¿ä
¼¼°è ¼øÈ¯±â°ú¿ë ÀüÀڰǰ±â·Ï(EHR) ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 31¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2033³â¿¡´Â 48¾ï 3,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2033³â CAGRÀº 4.9%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÀÌ ¼ºÀåÀº ½ÉÇ÷°ü Áúȯ(CVDs)ÀÇ ¼¼°è ºÎ´ã Áõ°¡¿¡ ÀÇÇØ ´õ¿í ÃËÁøµË´Ï´Ù. ¿¹¸¦ µé¾î, WHO¿¡ µû¸£¸é ½ÉÇ÷°ü Áúȯ(CVD)Àº Àü ¼¼°èÀûÀ¸·Î °¡Àå ³ôÀº »ç¸Á ¿øÀÎ Áß Çϳª·Î, ¸Å³â ¾à 1,790¸¸ ¸íÀÌ »ç¸ÁÇÕ´Ï´Ù. ½ÉÀ庴¿¡ ÀÖ¾î¼ È¯ÀÚ ÄɾîÀÇ °È°¡, ½ÃÀåÀ» ÇÑÃþ ´õ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. º¸´Ù »ó¼¼Çϰí Á¢±Ù°¡´ÉÇÑ ÀÌ·ÂÀ» °ü¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾î ½Ã±âÀûÀýÇÑ Áø´Ü°ú ¸ÂÃã Ä¡·á°èȹÀÌ °¡´ÉÇØÁý´Ï´Ù. ¶ÇÇÑ, ¸¸¼ºÁúȯÀÇ °ü¸®¿Í Àå±âÀûÀÎ °æ°ú°üÂûÀÌ Áß¿äÇÑ ½ÉÀ庴Çп¡¼´Â Àå±âÀûÀΠȯÀÚÀ̷µ¥ÀÌÅÍÀÇ ÃßÀûÀÌ Áß¿äÇÕ´Ï´Ù.
°Ô´Ù°¡ ´õ ³ªÀº ¸¸¼º Áúȯ °ü¸®ÀÇ Çʿ伺¿¡ ºÎÀÀÇÏ¿© ¹Ì±¹ Á¤ºÎ´Â EHR ½Ã½ºÅÛÀÇ µµÀÔÀ» ÃËÁøÇϱâ À§ÇØ ¸î °¡Áö Àǹ«¸¦ µµÀÔÇß½À´Ï´Ù. 2024³â 4¿ù ¹Ì±¹ ½ÉÀå Çùȸ(American Heart Association)¿¡¼ Wadhera¿Í Joynt Maddox°¡ ¹ßÇ¥ÇÑ "Policy Strategies to Advance Cardiovascular Health in the United States" (¹Ì±¹ ½ÉÇ÷°ü °Ç° ÁõÁøÀ» À§ÇÑ Á¤Ã¥ Àü·«)À̶ó´Â ³í¹®Àº ¹Ì±¹ÀÇ ½ÉÇ÷°ü °Ç°À» °³¼±Çϱâ À§ÇÑ º¸°Ç Á¤Ã¥µéÀ» ´Ù·ì´Ï´Ù.
¶ÇÇÑ 2024³â 6¿ù Athenahealth¿Í Cardiovascular Associates of ¾Æ¸Þ¸®Ä«(CVAUSA)´Â ÀÌ·¯ÇÑ Àü±¹ÀûÀÎ ³ë·Â°ú ¿¬°èÇÏ¿© ±Ý¾× ±âÁØ Äɾ Á¦°øÇÏ´Â µ¶¸³ ¼øÈ¯±â Àü¹®ÀǸ¦ Áö¿øÇϱâ À§ÇØ Á¦ÈÞÇß½À´Ï´Ù. ´ç»çÀÚ Âü¿© ¼Ö·ç¼ÇÀÎ athenaOne¿¡ ´ëÇÑ ¿ì¼± ¾×¼¼½º¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ Á¦ÈÞ´Â ÀÓ»ó ¹× À繫 ¼º°ú¸¦ Çâ»ó½Ã۰í, ¾÷¹«¸¦ °£¼ÒÈÇϰí, µ¥ÀÌÅÍ ÁÖµµ ÅëÂû·ÂÀ» Ȱ¿ëÇÏ¿© ȯÀÚÀÇ °á°ú¿Í Áø·áÀÇ Áö¼Ó°¡´É¼ºÀ» °³¼±ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.
±â¼ú Çõ½ÅÀº ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ ±â´É, »ç¿ë ÆíÀǼº, ÅëÇÕ ´É·ÂÀ» Çâ»ó½ÃÄÑ ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù. AI Agent, À½¼º ³»ºñ°ÔÀ̼Ç, Health Data Intelligence µî AI ÁÖµµÀÇ ÅøÀÌ ÅëÇÕµÉ Àü¸ÁÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§
½ÃÀå °èÅëÀÇ Àü¸Á
½ÃÀå ¿ªÇÐ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
ÀÌ¿ë »ç·Ê
ºñÁî´Ï½º ȯ°æ ºÐ¼®
Porter's Five Forces ºÐ¼®
PESTLE ºÐ¼®
Á¦4Àå Á¦Ç° ºñÁî´Ï½º ºÐ¼®
Á¦Ç° ½ÃÀå Á¡À¯À², 2024³â°ú 2033³â
Á¦Ç° ºÎ¹® ´ë½Ãº¸µå
½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®(Á¦Ç°º°, 2021-2033³â)
À¥/Ŭ¶ó¿ìµå ±â¹Ý EHR
À¥/Ŭ¶ó¿ìµå ±â¹Ý EHR ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
On-Premise EHR
On-Premise EHR ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
Á¦5Àå ºñÁî´Ï½º ¸ðµ¨ ºñÁî´Ï½º ºÐ¼®
ºñÁî´Ï½º ¸ðµ¨ ½ÃÀå Á¡À¯À², 2024³â°ú 2033³â
ºñÁî´Ï½º ¸ðµ¨ ºÎ¹® ´ë½Ãº¸µå
½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®(ºñÁî´Ï½º ¸ðµ¨º°, 2021-2033³â)
¶óÀ̼±½º ¼ÒÇÁÆ®¿þ¾î
¶óÀ̼±½º ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
±â¼ú ÀçÆÇ¸Å
±â¼ú ÀçÆÇ¸Å ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
±¸µ¶
±¸µ¶ ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
Àü¹® ¼ºñ½º
ÇÁ·ÎÆä¼Å³Î ¼ºñ½º ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
±âŸ(Áö¿ø ¹× À¯Áö º¸¼ö, °ü¸® ¼ºñ½º µî)
±âŸ(Áö¿ø ¹× À¯Áö°ü¸®, ¸Å´ÏÁöµå ¼ºñ½º µî) ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
Á¦6Àå ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®
ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â°ú 2033³â
ÃÖÁ¾ ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®(ÃÖÁ¾ ¿ëµµº°, 2021-2033³â)
º´¿ø
º´¿ø ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
±âŸ
±âŸ ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
Á¦7Àå Á¦Ç°, ºñÁî´Ï½º ¸ðµ¨, ÃÖÁ¾ ¿ëµµ¿¡ µû¸¥ Áö¿ªº°, ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®
Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2033³â
Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
½ÃÀå ±Ô¸ð¿Í ¿¹Ãø µ¿Ç⠺м®, 2021-2033³â
ºÏ¹Ì
ºÏ¹ÌÀÇ ¼øÈ¯±â°ú¿ë ÀüÀڰǰ±â·Ï( EHR) ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
¹Ì±¹
ij³ª´Ù
¸ß½ÃÄÚ
À¯·´
À¯·´ÀÇ ¼øÈ¯±â°ú¿ë ÀüÀڰǰ±â·Ï( EHR) ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
µ¶ÀÏ
¿µ±¹
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
µ§¸¶Å©
½º¿þµ§
³ë¸£¿þÀÌ
¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼øÈ¯±â°ú¿ë ÀüÀڰǰ±â·Ï( EHR) ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
ÀϺ»
Áß±¹
Àεµ
Çѱ¹
È£ÁÖ
ű¹
¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¼øÈ¯±â°ú¿ë ÀüÀڰǰ±â·Ï( EHR) ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
ºê¶óÁú
¾Æ¸£ÇîÆ¼³ª
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼øÈ¯±â°ú¿ë ÀüÀڰǰ±â·Ï( EHR) ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, 2021-2033³â
³²¾ÆÇÁ¸®Ä«
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
Äí¿þÀÌÆ®
Á¦8Àå °æÀï ±¸µµ
Âü°¡ÀÚ °³¿ä
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´× ºÐ¼®
±â¾÷ ºÐ·ù
Àü·« ¸ÅÇÎ
±â¾÷ ÇÁ·ÎÆÄÀÏ/»óÀå ±â¾÷
Epic Systems Corporation
Oracle
Veradigm LLC
GE HealthCare.
Philips Healthcare
McKesson Corporation
eClinicalWorks
NextGen Healthcare, Inc.
athenahealth, Inc.
Greenway Health, LLC
SHW
¿µ¹® ¸ñÂ÷
Cardiology EHR Market Summary
The global cardiology EHR market size was estimated at USD 3.16 billion in 2024, and is projected to reach USD 4.83 billion by 2033, growing at a CAGR of 4.9% from 2025 to 2033. The growing focus on improved patient care, the need for long-term patient record tracking, improved clinical decision-making, and technological advancements contribute to market growth.
This growth is further propelled by the escalating global burden of cardiovascular diseases (CVDs). For instance, according to the WHO, cardiovascular diseases (CVDs) are one of the highest causes of death globally, accounting for approximately 17.9 million deaths each year. Enhanced patient care in cardiology is further driving the market. Electronic health records allow healthcare providers to maintain a detailed and accessible history of a patient's cardiovascular health, enabling timely diagnosis and personalized treatment plans. In addition, tracking long-term historical patient data is important in cardiology, where managing chronic conditions and monitoring progress over time is critical. Electronic Health Record (EHR) systems facilitate this by consolidating data from multiple visits, tests, and procedures into a comprehensive digital file.
Moreover, in response to the need for better chronic disease management, the U.S. government introduced several mandates to accelerate the adoption of EHR systems. These policies aimed to improve care coordination, enable data-driven decisions, and enhance preventive care, especially for conditions such as cardiovascular disease. The article "Policy Strategies to Advance Cardiovascular Health in the United States" by Wadhera and Joynt Maddox, published in the American Heart Association in April 2024, examines U.S. health policies to improve cardiovascular health. It highlights the impact of the Affordable Care Act in expanding preventive services and discusses ongoing challenges and strategies to enhance cardiovascular outcomes through policy interventions.
Furthermore, aligning with these national efforts, in June 2024, Athenahealth and Cardiovascular Associates of America (CVAUSA) partnered to support independent cardiologists in delivering value-based care. CVAUSA-affiliated practices gain preferred access to athenaOne, an electronic health record (EHR) suite, revenue cycle management (RCM), and patient engagement solutions. This collaboration aims to enhance clinical and financial performance, streamline operations, and leverage data-driven insights to improve patient outcomes and practice sustainability.
Technological innovations are significantly accelerating market growth by improving these systems' functionality, usability, and integration capabilities. Advances such as cloud-based platforms and artificial intelligence (AI) enable more efficient data management and deeper insights into patient health trends. For instance, Oracle Health is set to launch a next-generation electronic health record (EHR) platform in 2025. The platform is expected to integrate AI-driven tools such as a Clinical AI Agent, voice navigation, and Health Data Intelligence. Built on Oracle Cloud Infrastructure, it aims to enhance clinical workflows, support personalized care, and advance value-based healthcare delivery.
Global Cardiology EHR Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cardiology EHR market report based on product, business model, end use, and region:
Product Outlook (Revenue, USD Billion, 2021 - 2033)
Web/ cloud-based EHR
On-premise EHR
Business Model Outlook (Revenue, USD Billion, 2021 - 2033)
Licensed Software
Technology Resale
Subscriptions
Professional Services
Others (Support & Maintenance, Managed Services, etc.)
End Use Size Outlook (Revenue, USD Billion, 2021 - 2033)
Hospital
Ambulatory Surgical Centers
Other end use
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Business Model
1.2.3. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR's Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increase in need for improved patient care
3.2.1.2. Government Initiatives and Regulations
3.2.1.3. Advancements in Technology
3.2.2. Market Restraint Analysis
3.2.2.1. High Implementation and Maintenance Costs
3.2.2.2. Data Privacy and Security Concerns
3.3. Case Studies
3.4. Business Environment Analysis
3.4.1. Porter's Five Forces Analysis
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTLE Analysis
Chapter 4. Product Business Analysis
4.1. Product Market Share, 2024 & 2033
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Billion)
4.4. Web/Cloud-Based EHR
4.4.1. Web/cloud Based EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
4.5. On-premise EHR
4.5.1. On-premise EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 5. Business Model Business Analysis
5.1. Business Model Market Share, 2024 & 2033
5.2. Business Model Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, by Business Model, 2021 to 2033 (USD Billion)
5.4. Licensed Software
5.4.1. Licensed software market estimates and forecasts, 2021 - 2033 (USD Billion)
5.5. Technology Resale
5.5.1. Technology resale market estimates and forecasts, 2021 - 2033 (USD Billion)
5.6. Subscriptions
5.6.1. Subscriptions market estimates and forecasts, 2021 - 2033 (USD Billion)
5.7. Professional Services
5.7.1. Professional services market estimates and forecasts, 2021 - 2033 (USD Billion)
5.8. Others (Support & Maintenance, Managed Services, etc.)
5.8.1. Others (Support & Maintenance, Managed Services, etc.) market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 6. End Use Business Analysis
6.1. End Use Market Share, 2024 & 2033
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, by End Use, 2021 to 2033 (USD Billion)
6.4. Hospital
6.4.1. Hospital market estimates and forecasts, 2021 - 2033 (USD Billion)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory Surgical Centers market estimates and forecasts, 2021 - 2033 (USD Billion)
6.6. Other end use
6.6.1. Other end use market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 7. Regional Estimates & Trend Analysis by Product, Business Model, End Use
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. North America Cardiology EHR Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.4.2. U.S.
7.4.2.1. Key country dynamic
7.4.2.2. Regulatory framework
7.4.2.3. Competitive insights
7.4.2.4. U.S. cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.4.3. Canada
7.4.3.1. Key country dynamic
7.4.3.2. Regulatory framework
7.4.3.3. Competitive insights
7.4.3.4. Canada cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.4.4. Mexico
7.4.4.1. Key country dynamic
7.4.4.2. Regulatory framework
7.4.4.3. Competitive insights
7.4.4.4. Mexico cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.5. Europe
7.5.1. Europe Cardiology EHR Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5.2. Germany
7.5.2.1. Key country dynamic
7.5.2.2. Regulatory framework
7.5.2.3. Competitive insights
7.5.2.4. Germany cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.5.3. UK
7.5.3.1. Key country dynamic
7.5.3.2. Regulatory framework
7.5.3.3. Competitive insights
7.5.3.4. UK cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.5.4. France
7.5.4.1. Key country dynamic
7.5.4.2. Regulatory framework
7.5.4.3. Competitive insights
7.5.4.4. France cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.5.5. Italy
7.5.5.1. Key country dynamic
7.5.5.2. Regulatory framework
7.5.5.3. Competitive insights
7.5.5.4. Italy cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.5.6. Spain
7.5.6.1. Key country dynamic
7.5.6.2. Regulatory framework
7.5.6.3. Competitive insights
7.5.6.4. Spain cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.5.7. Denmark
7.5.7.1. Key country dynamic
7.5.7.2. Regulatory framework
7.5.7.3. Competitive insights
7.5.7.4. Denmark cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.5.8. Sweden
7.5.8.1. Key country dynamic
7.5.8.2. Regulatory framework
7.5.8.3. Competitive insights
7.5.8.4. Sweden cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.5.9. Norway
7.5.9.1. Key country dynamic
7.5.9.2. Regulatory framework
7.5.9.3. Competitive insights
7.5.9.4. Norway cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.6. Asia Pacific
7.6.1. Asia Pacific Cardiology EHR Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6.2. Japan
7.6.2.1. Key country dynamic
7.6.2.2. Regulatory framework
7.6.2.3. Competitive insights
7.6.2.4. Japan cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.6.3. China
7.6.3.1. Key country dynamic
7.6.3.2. Regulatory framework
7.6.3.3. Competitive insights
7.6.3.4. China cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.6.4. India
7.6.4.1. Key country dynamic
7.6.4.2. Regulatory framework
7.6.4.3. Competitive insights
7.6.4.4. India cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.6.5. South Korea
7.6.5.1. Key country dynamic
7.6.5.2. Regulatory framework
7.6.5.3. Competitive insights
7.6.5.4. South Korea cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.6.6. Australia
7.6.6.1. Key country dynamic
7.6.6.2. Regulatory framework
7.6.6.3. Competitive insights
7.6.6.4. Australia cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.6.7. Thailand
7.6.7.1. Key country dynamic
7.6.7.2. Regulatory framework
7.6.7.3. Competitive insights
7.6.7.4. Thailand cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.7. Latin America
7.7.1. Latin America Cardiology EHR Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.7.2. Brazil
7.7.2.1. Key country dynamic
7.7.2.2. Regulatory framework
7.7.2.3. Competitive insights
7.7.2.4. Brazil cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.7.3. Argentina
7.7.3.1. Key country dynamic
7.7.3.2. Regulatory framework
7.7.3.3. Competitive insights
7.7.3.4. Argentina cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.8. MEA
7.8.1. MEA Cardiology EHR Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.8.2. South Africa
7.8.2.1. Key country dynamic
7.8.2.2. Regulatory framework
7.8.2.3. Competitive insights
7.8.2.4. South Africa cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamic
7.8.3.2. Regulatory framework
7.8.3.3. Competitive insights
7.8.3.4. Saudi Arabia cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.8.4. UAE
7.8.4.1. Key country dynamic
7.8.4.2. Regulatory framework
7.8.4.3. Competitive insights
7.8.4.4. UAE cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
7.8.5. Kuwait
7.8.5.1. Key country dynamic
7.8.5.2. Regulatory framework
7.8.5.3. Competitive insights
7.8.5.4. Kuwait cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Epic Systems Corporation
8.5.1.1. Overview
8.5.1.2. Financial performance
8.5.1.3. Product benchmarking
8.5.1.4. Strategic initiatives
8.5.2. Oracle
8.5.2.1. Overview
8.5.2.2. Financial performance
8.5.2.3. Product benchmarking
8.5.2.4. Strategic initiatives
8.5.3. Veradigm LLC
8.5.3.1. Overview
8.5.3.2. Financial performance
8.5.3.3. Product benchmarking
8.5.3.4. Strategic initiatives
8.5.4. GE HealthCare.
8.5.4.1. Overview
8.5.4.2. Financial performance
8.5.4.3. Product benchmarking
8.5.4.4. Strategic initiatives
8.5.5. Philips Healthcare
8.5.5.1. Overview
8.5.5.2. Financial performance
8.5.5.3. Product benchmarking
8.5.5.4. Strategic initiatives
8.5.6. McKesson Corporation
8.5.6.1. Overview
8.5.6.2. Financial performance
8.5.6.3. Product benchmarking
8.5.6.4. Strategic initiatives
8.5.7. eClinicalWorks
8.5.7.1. Overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. NextGen Healthcare, Inc.
8.5.8.1. Overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. athenahealth, Inc.
8.5.9.1. Overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Greenway Health, LLC
8.5.10.1. Overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic initiatives
°ü·ÃÀÚ·á